Psychomotor stimulants

Psychomotor stimulants

Watch later

Watch later

Anatomy of the thyroid and parathyroid glands
Pediatric lower airway conditions: Clinical
Analgesics: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Introduction to pharmacology
Nitrates: Nursing pharmacology
Sexually transmitted infections: Clinical
Seizures: Pathology review
Seizures: Clinical
Seizures and epilepsy
Intracerebral hemorrhage
Brain herniation
Traumatic brain injury: Clinical
Traumatic brain injury: Pathology review
Adult brain tumors
Ischemic stroke
Stroke: Clinical
Alzheimer disease
Endocrine system anatomy and physiology
Adaptive teaching
Dementia and delirium: Clinical
Dementia: Pathology review
Huntington disease
Calcium-channel blockers: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Pharmacokinetics - Elimination: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Analgesics for obstetrics: Nursing pharmacology
Lung surfactants and antenatal corticosteroids: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Antipsychotics: Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Oxygen binding capacity and oxygen content
The role of the kidney in acid-base balance
Glomerular filtration
Loop of Henle
Abdominal quadrants, regions and planes
Abdominal trauma: Clinical
Gastrointestinal system anatomy and physiology
Antihistamines: Nursing pharmacology
Blood products: Nursing pharmacology
Hemostatics: Nursing pharmacology
Insulin: Nursing pharmacology
Tocolytics: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Alpha-1 adrenergic blockers: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Pharmacokinetics - Metabolism: Nursing pharmacology
ECG basics
ECG axis
ECG QRS transition
ECG intervals
ECG rate and rhythm
ECG normal sinus rhythm
ECG cardiac infarction and ischemia
Echinococcus granulosus (Hydatid disease)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class III antiarrhythmics: Potassium channel blockers
Heart failure: Clinical
Psychomotor stimulants
Calcium channel blockers
Monoamine oxidase inhibitors
Medications for Alzheimer disease: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Antiplatelet medications
Introduction to the immune system
Blood components
Erythropoietin
Neck trauma: Clinical
Chest trauma: Clinical
Reading a chest X-ray
Anatomy of the heart
Supraventricular arrhythmias: Pathology review
Pharmacy school: Dosage calculations
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome

Transcript

Watch video only

Psychomotor stimulants are drugs that stimulate the central nervous system to increase motor activity and to produce euphoria, excitement, and a feeling of having lots of energy.

Unfortunately, some drugs of abuse, like methamphetamine or cocaine, belong to this class of substances.

However, there are a few medications in this class that do have clinical applications so let’s go over those.

To understand how psychomotor stimulants work, let’s zoom in on one of the synapses of the brain.

Normally electrical signals, or action potentials, travel down the axon to the axon terminal, where they trigger the release of chemical messengers, called neurotransmitters, from synaptic vesicles into the synapse.

The neurotransmitters travel across the synapse and bind to receptors on the postsynaptic neuron, where they give the cell a message.

After the neurotransmitters have done their job, they unbind from the receptors, and can: diffuse away, get degraded by enzymes, or get picked up by proteins and returned to their original release site in a process called reuptake.

Psychomotor stimulants, in general, increase the release of certain neurotransmitters, but their biggest effect is blocking reuptake receptors on presynaptic axon terminals.

Both actions keep neurotransmitters - like dopamine, norepinephrine, and serotonin - in the synapse longer, and increases their effects.

For example, increased concentrations of dopamine in the brain’s reward pathway, which includes the nucleus accumbens, ventral tegmentum, and prefrontal cortex, produce intense feelings of euphoria, pleasure, and the emotional “high” associated with psychomotor stimulants.

The physical “high” or feeling of hyper-stimulation is caused by increased norepinephrine concentrations throughout the brain, which produces a variety of effects throughout the body like increased energy, constricted blood vessels, dilated pupils, increased body temperature, increased heart rate, and increased blood pressure.

And finally, higher levels of serotonin are associated with greater confidence and happiness, and decreased anxiety.

Okay, for psychomotor stimulants with medical applications, let’s start with the popular methylxanthines.

We are all familiar with this class of medication since it includes caffeine and theophylline found in coffee and tea respectively.

Now both these substances cause a stimulatory effect by blocking receptors for adenosine, a chemical that has numerous effects in the body like decreasing heart rate, decreasing neuronal activity - triggering sleepiness, and dilating blood vessels.

Now, migraines and other headaches can be caused by increased adenosine levels in the brain, so caffeine is often combined with an NSAID or acetaminophen to treat them.

Theophylline, on the other hand, is used to treat respiratory disorders like COPD and asthma.

It works by inhibiting the enzyme phosphodiesterase, or PDE, in the smooth muscles in the respiratory tract.

Normally phosphodiesterase converts cAMP into an inactive form called 5-AMP.

By inhibiting this enzyme, we increase the level of cAMP within the cell, and trigger smooth muscle relaxation and bronchodilation.

An overdose of methylxanthines can cause anxiety, nausea, arrhythmia, and seizures, so watch your coffee intake!

Another medication that can help you stay awake is Modafinil.

It’s mainly used to treat narcolepsy, a condition where the person can fall asleep at any moment of the day and has episodes of paralysis out of the blue - not cool, right?

Well, modafinil inhibits dopamine reuptake and increases the release of glutamate and histamine in the brain, all of which increases arousal.

Modafinil is sometimes used as a “cognitive enhancer” off-label, but there’s no research to support this claim.

Okay, let’s move on to the next group of medication like amphetamines and methylphenidate which work by blocking the reuptake of dopamine and norepinephrine at the presynaptic neuron.

It’s the preferred treatment for attention deficit/hyperactivity disorder, or ADHD for short, because it helps improve focus and decreases the impulsivity common in people with this disorder.

It also doesn’t have major side effects, making it the preferred medication.

Finally, we have cocaine, sometimes called coke, which is a powerful psychomotor stimulant that has been used for over a thousand years.

Key Takeaways

Psychomotor stimulants are medications that stimulate the central nervous system to increase alertness, attention, and energy levels. Some psychomotor stimulants, like modafinil, methylphenidate, and cocaine work by increasing the amount of dopamine, norepinephrine, and serotonin in the synapse by preventing their reuptake. Others, like the methylxanthines, block the action of adenosine, which normally decreases neuronal activity and causes drowsiness. Common side effects include agitation; insomnia, tachycardia, hypertension, tics, and anorexia.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Behavioral effects of caffeine and other methylxanthines on children" Exp Clin Psychopharmacol (1998)
  5. " Caffeine and theophylline counteract diazepam effects in man" Med Biol (1983)
  6. "Amphetamine, past and present--a pharmacological and clinical perspective" J Psychopharmacol (Oxford) (2013)
  7. "Autonomic actions of cocaine" Can J Physiol Pharmacol (1989)
  8. "Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review" Eur Neuropsychopharmacol (2015)